(CAP) Capgemini SE - Ratings and Ratios
Consulting, Digital Transformation, Technology Services, Engineering Services
Dividends
| Dividend Yield | 2.30% |
| Yield on Cost 5y | 3.22% |
| Yield CAGR 5y | 25.98% |
| Payout Consistency | 71.5% |
| Payout Ratio | 38.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.0% |
| Value at Risk 5%th | 46.3% |
| Relative Tail Risk | -6.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.03 |
| Alpha | -8.84 |
| CAGR/Max DD | -0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.581 |
| Beta | 0.284 |
| Beta Downside | 0.495 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.04% |
| Mean DD | 19.07% |
| Median DD | 14.75% |
Description: CAP Capgemini SE October 16, 2025
Capgemini SE (ticker CAP) is a French-headquartered, globally diversified provider of consulting, digital transformation, technology, and engineering services, operating across North America, Europe, APAC and Latin America.
The firm delivers end-to-end offerings that include strategy and transformation (technology, data science, creative design), application development, cloud infrastructure, and business process outsourcing, with deep expertise in data strategy, AI, and analytics. In FY 2023, Capgemini generated €18.2 billion in revenue and posted an operating margin of roughly 14 %, while its cloud services line grew about 20 % year-over-year, reflecting robust demand for agile, secure digital foundations.
Capgemini serves a broad portfolio of sectors-Aerospace & Defense, Automotive, Banking & Capital Markets, Consumer Products, Energy & Utilities, Healthcare, High-Tech, Hospitality & Travel, Insurance, Life Sciences, Manufacturing, Media & Entertainment, Public Sector, Retail, and Telecoms-positioning it to benefit from the projected $2.3 trillion global spend on digital transformation by 2025.
For a deeper quantitative assessment of Capgemini’s valuation metrics and peer comparison, the ValueRay platform offers a data-driven dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (2.89b TTM) > 0 and > 6% of Revenue (6% = 2.32b TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 8.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.22% (prev 9.83%; Δ -7.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 5.20b > Net Income 2.89b (YES >=105%, WARN >=100%) |
| Net Debt (3.96b) to EBITDA (5.28b) ratio: 0.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (176.2m) change vs 12m ago -1.09% (target <= -2.0% for YES) |
| Gross Margin 26.70% (prev 25.62%; Δ 1.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 155.2% (prev 106.7%; Δ 48.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.92 (EBITDA TTM 5.28b / Interest Expense TTM 258.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.08
| (A) 0.04 = (Total Current Assets 8.91b - Total Current Liabilities 8.05b) / Total Assets 24.38b |
| (B) 0.32 = Retained Earnings (Balance) 7.82b / Total Assets 24.38b |
| (C) 0.17 = EBIT TTM 4.37b / Avg Total Assets 24.97b |
| (D) 0.60 = Book Value of Equity 8.01b / Total Liabilities 13.39b |
| Total Rating: 3.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.25
| 1. Piotroski 8.50pt |
| 2. FCF Yield 15.92% |
| 3. FCF Margin 11.59% |
| 4. Debt/Equity 0.55 |
| 5. Debt/Ebitda 0.75 |
| 6. ROIC - WACC (= 17.67)% |
| 7. RoE 26.22% |
| 8. Rev. Trend 30.26% |
| 9. EPS Trend -10.65% |
What is the price of CAP shares?
Over the past week, the price has changed by +2.15%, over one month by +9.41%, over three months by +19.22% and over the past year by -3.82%.
Is CAP a buy, sell or hold?
What are the forecasts/targets for the CAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 171.9 | 16.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 150.9 | 2.3% |
CAP Fundamental Data Overview December 12, 2025
Market Cap EUR = 24.26b (24.26b EUR * 1.0 EUR.EUR)
P/E Trailing = 16.4527
P/E Forward = 11.3636
P/S = 1.0994
P/B = 2.2221
P/EG = 1.1135
Beta = 0.842
Revenue TTM = 38.75b EUR
EBIT TTM = 4.37b EUR
EBITDA TTM = 5.28b EUR
Long Term Debt = 3.48b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.96b EUR (from shortTermDebt, last quarter)
Debt = 6.07b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.96b EUR (from netDebt column, last quarter)
Enterprise Value = 28.22b EUR (24.26b + Debt 6.07b - CCE 2.11b)
Interest Coverage Ratio = 16.92 (Ebit TTM 4.37b / Interest Expense TTM 258.0m)
FCF Yield = 15.92% (FCF TTM 4.49b / Enterprise Value 28.22b)
FCF Margin = 11.59% (FCF TTM 4.49b / Revenue TTM 38.75b)
Net Margin = 7.45% (Net Income TTM 2.89b / Revenue TTM 38.75b)
Gross Margin = 26.70% ((Revenue TTM 38.75b - Cost of Revenue TTM 28.40b) / Revenue TTM)
Gross Margin QoQ = 26.43% (prev 28.09%)
Tobins Q-Ratio = 1.16 (Enterprise Value 28.22b / Total Assets 24.38b)
Interest Expense / Debt = 1.32% (Interest Expense 80.0m / Debt 6.07b)
Taxrate = 26.37% (130.0m / 493.0m)
NOPAT = 3.22b (EBIT 4.37b * (1 - 26.37%))
Current Ratio = 1.11 (Total Current Assets 8.91b / Total Current Liabilities 8.05b)
Debt / Equity = 0.55 (Debt 6.07b / totalStockholderEquity, last quarter 10.97b)
Debt / EBITDA = 0.75 (Net Debt 3.96b / EBITDA 5.28b)
Debt / FCF = 0.88 (Net Debt 3.96b / FCF TTM 4.49b)
Total Stockholder Equity = 11.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.84% (Net Income 2.89b / Total Assets 24.38b)
RoE = 26.22% (Net Income TTM 2.89b / Total Stockholder Equity 11.01b)
RoCE = 30.12% (EBIT 4.37b / Capital Employed (Equity 11.01b + L.T.Debt 3.48b))
RoIC = 23.51% (NOPAT 3.22b / Invested Capital 13.67b)
WACC = 5.84% (E(24.26b)/V(30.33b) * Re(7.06%) + D(6.07b)/V(30.33b) * Rd(1.32%) * (1-Tc(0.26)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.17%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈3.69b ; Y1≈4.55b ; Y5≈7.76b
Fair Price DCF = 796.9 (DCF Value 131.99b / Shares Outstanding 165.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -10.65 | EPS CAGR: -61.90% | SUE: 0.0 | # QB: 0
Revenue Correlation: 30.26 | Revenue CAGR: -12.42% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=12.77 | Chg30d=+0.074 | Revisions Net=+8 | Growth EPS=+8.5% | Growth Revenue=+6.4%